LAURA O'KEEFE: Open Payments
NPI 1639552490 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 15 payments from 8 companies in 2025. Trend: 2023 $624 · 2024 $714 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $219 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| Baxter Healthcare | 2 | $50 |
| Amgen Inc. | 3 | $50 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Boston Scientific Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| PFIZER INC. | 1 | $17 |
Products named: PASCAL, CAMZYOS, Hillrom - Carnation Ambulatory Monitor, REPATHA, VERQUVO, WATCHMAN Access System, JOT DX, VYNDAQEL.
Industry payments across MS — which companies pay providers there.
